ResMed Inc. (RMD)
ResMed Statistics
Share Statistics
ResMed has 146.87M shares outstanding. The number of shares has increased by -0.03% in one year.
| Shares Outstanding | 146.87M |
| Shares Change (YoY) | -0.03% |
| Shares Change (QoQ) | 0.05% |
| Owned by Institutions (%) | 61.28% |
| Shares Floating | 145.81M |
| Failed to Deliver (FTD) Shares | 3.99K |
| FTD / Avg. Volume | 0.36% |
Short Selling Information
The latest short interest is 8.9M, so 6.06% of the outstanding shares have been sold short.
| Short Interest | 8.9M |
| Short % of Shares Out | 6.06% |
| Short % of Float | 6.97% |
| Short Ratio (days to cover) | 11.41 |
Valuation Ratios
The PE ratio is 26.92 and the forward PE ratio is 20.33. ResMed's PEG ratio is 2.01.
| PE Ratio | 26.92 |
| Forward PE | 20.33 |
| PS Ratio | 5.87 |
| Forward PS | 4.5 |
| PB Ratio | 5.65 |
| P/FCF Ratio | 21.37 |
| PEG Ratio | 2.01 |
Enterprise Valuation
ResMed has an Enterprise Value (EV) of 28.12B.
| EV / Sales | 6 |
| EV / EBITDA | 18.34 |
| EV / EBIT | 20.07 |
| EV / FCF | 21.86 |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.59 |
| Quick Ratio | 1.69 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 0.57 |
| Debt / FCF | 0.68 |
| Interest Coverage | 28.88 |
Financial Efficiency
Return on Equity is 20.99% and Return on Invested Capital is 17.69%.
| Return on Equity | 20.99% |
| Return on Assets | 14.86% |
| Return on Invested Capital | 17.69% |
| Revenue Per Employee | $469.47K |
| Profits Per Employee | $102.3K |
| Employee Count | 9,980 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 2.47 |
Taxes
| Income Tax | 243.85M |
| Effective Tax Rate | 19.28% |
Stock Price Statistics
The stock price has increased by 19.85% in the last 52 weeks. The beta is 0.76, so ResMed's price volatility has been higher than the market average.
| Beta | 0.76 |
| 52-Week Price Change | 19.85% |
| 50-Day Moving Average | 224.84 |
| 200-Day Moving Average | 231.53 |
| Relative Strength Index (RSI) | 44.78 |
| Average Volume (20 Days) | 1.1M |
Income Statement
In the last 12 months, ResMed had revenue of 4.69B and earned 1.02B in profits. Earnings per share was 6.94.
| Revenue | 4.69B |
| Gross Profit | 2.66B |
| Operating Income | 1.32B |
| Net Income | 1.02B |
| EBITDA | 1.53B |
| EBIT | 1.31B |
| Earnings Per Share (EPS) | 6.94 |
Balance Sheet
The company has 238.36M in cash and 873.93M in debt, giving a net cash position of -635.57M.
| Cash & Cash Equivalents | 238.36M |
| Total Debt | 873.93M |
| Net Cash | -635.57M |
| Retained Earnings | 4.99B |
| Total Assets | 7.14B |
| Working Capital | 1.98B |
Cash Flow
In the last 12 months, operating cash flow was 1.4B and capital expenditures -114.86M, giving a free cash flow of 1.29B.
| Operating Cash Flow | 1.4B |
| Capital Expenditures | -114.86M |
| Free Cash Flow | 1.29B |
| FCF Per Share | 8.75 |
Margins
Gross margin is 56.67%, with operating and profit margins of 28.17% and 21.79%.
| Gross Margin | 56.67% |
| Operating Margin | 28.17% |
| Pretax Margin | 27% |
| Profit Margin | 21.79% |
| EBITDA Margin | 32.73% |
| EBIT Margin | 28.17% |
| FCF Margin | 27.46% |
Dividends & Yields
RMD pays an annual dividend of $2.07, which amounts to a dividend yield of 0.86%.
| Dividend Per Share | $2.07 |
| Dividend Yield | 0.86% |
| Dividend Growth (YoY) | 10.42% |
| Payout Ratio | 24.44% |
| Earnings Yield | 3.71% |
| FCF Yield | 4.68% |
Analyst Forecast
The average price target for RMD is $265, which is 24.5% higher than the current price. The consensus rating is "Hold".
| Price Target | $265 |
| Price Target Difference | 24.5% |
| Analyst Consensus | Hold |
| Analyst Count | 11 |
Stock Splits
The last stock split was on Aug 31, 2010. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 31, 2010 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 12.83 |
| Piotroski F-Score | 9 |